Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fortelyzin vs Tenecteplase in STEMI (FRIDOM1)
NCT02301910Phase 3Completed
- Sponsor
- SuperGen, Inc.
- Start
- May 2014
- Primary completion
- Dec 2016
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of staphylokinase in ST elevation myocardial infarction (STEMI), sponsored by SuperGen, Inc.. Started May 2014; status: completed.
02
Drugs
staphylokinase
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT02301910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02301910.